메뉴 건너뛰기




Volumn 16, Issue 4, 2012, Pages 418-420

Dermatologic assessment from a distance: The use of teledermatology in an outpatient chemotherapy infusion center

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84868015529     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/12.CJON.418-420     Document Type: Article
Times cited : (10)

References (6)
  • 2
    • 84872829895 scopus 로고    scopus 로고
    • Retrieved from
    • American Telemedicine Association. (2011). About telemedicine. Retrieved from http://www.americantelemed.org/i4a/pages/index.cfm?pageID=3308
    • (2011) About Telemedicine
  • 3
    • 84984568870 scopus 로고    scopus 로고
    • Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
    • MASCC Skin Toxicity Group, doi: 10.1007/S00520-011-1197-6
    • Lacouture, M., Anadkat, M. J., Bensadoun, R., Bryce, J., Chan, A., Epstein, J. B. MASCC Skin Toxicity Group. (2011). Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive Care in Cancer, 19, 1079-1095. doi: 10.1007/S00520-011- 1197-6
    • (2011) Supportive Care in Cancer , vol.19 , pp. 1079-1095
    • Lacouture, M.1    Anadkat, M.J.2    Bensadoun, R.3    Bryce, J.4    Chan, A.5    Epstein, J.B.6
  • 4
    • 33748466742 scopus 로고    scopus 로고
    • The PRIDE (papulopustules and/or paronychia, regulatory abnormalities of hair growth, itching, and dryness due to epidermal growth factor receptor inhibitors) syndrome
    • doi: 10.1111/j.1365-21332006.07452.x
    • Lacouture, M. E., & Lai, S. E. (2006). The PRIDE (papulopustules and/or paronychia, regulatory abnormalities of hair growth, itching, and dryness due to epidermal growth factor receptor inhibitors) syndrome. British Journal of Dermatology, 155, 852-854. doi: 10.1111/j.1365-21332006.07452.x
    • (2006) British Journal of Dermatology , vol.155 , pp. 852-854
    • Lacouture, M.E.1    Lai, S.E.2
  • 5
    • 38849178281 scopus 로고    scopus 로고
    • Clinical approaches to minimize rash associated with EGFR inhibitors
    • doi:10.1188/08. ONF.103-111
    • Oishi, K. (2008). Clinical approaches to minimize rash associated with EGFR inhibitors. Oncology Nursing Forum, 35, 103-111. doi:10.1188/08. ONF.103-111
    • (2008) Oncology Nursing Forum , vol.35 , pp. 103-111
    • Oishi, K.1
  • 6
    • 24044500971 scopus 로고    scopus 로고
    • Clinical signs, pathophysiology, and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
    • doi:10.1093/annonc/mdi279
    • Segaert, S., & Van Cutsem, E. (2005). Clinical signs, pathophysiology, and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Annals of Oncology, 16, 1425-1433. doi:10.1093/annonc/mdi279
    • (2005) Annals of Oncology , vol.16 , pp. 1425-1433
    • Segaert, S.1    Van Cutsem, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.